| Filed On | Filing |
|---|---|
| 06 Sep 2024 |
Form 3: Dupont Jakob, Director
No securities owned |
| 15 May 2024 |
Form 3: Nemec Sarah, Principal Accounting Officer
Holds 11,363 shares of Common Stock |
| 16 Dec 2022 |
Form 3: Berner Laura, Director
Holds 0 shares of No securities are beneficially owned |
| 16 Dec 2021 |
Form 3: Onetto Nicole, Director
Holds 0 shares of No securities are beneficially owned |
| 19 Nov 2021 |
Form 3: Lee Frank D., Director
Holds 0 shares of No securities are beneficially owned. |
| 19 Nov 2021 |
Form 3: O'callaghan Brian, Director
Holds 0 shares of No securities are beneficially owned. |
| 04 Feb 2021 | Form 3: Sofinnova Venture Partners X, L.p., 10% owner and 3 others |
| 04 Feb 2021 | Form 3: Perez Edith A., Chief Medical Officer |
| 04 Feb 2021 |
Form 3: Vivo Capital VIII, Llc, 10% owner and 4 others
Holds 25,104 shares of Common Stock |
| 04 Feb 2021 | Form 3: Laporte Kathleen, Director |
| 04 Feb 2021 |
Form 3: Shah Mahendra, Director
Holds 14,285 shares of Common Stock |
| 04 Feb 2021 | Form 3: Healy James, Director |
| 04 Feb 2021 |
Form 3: Miller Richard A Md, Director
Holds 15,602 shares of Common Stock |
| 04 Feb 2021 | Form 3: Khanna Ashish Siri Ram, Director |
| 04 Feb 2021 |
Form 3: Engleman Edgar, Director
Holds 577,425 shares of Common Stock |
| 04 Feb 2021 |
Form 3: Moldt Peter, Director
No securities owned |
| 04 Feb 2021 | Form 3: Yonehiro Grant, Chief Business Officer |
| 04 Feb 2021 | Form 3: Dornan David, Chief Scientific Officer |
| 04 Feb 2021 |
Form 3: Novo Holdings A/S, 10% owner
Holds 76,903 shares of COMMON STOCK |
| 04 Feb 2021 |
Form 3: Quinn William P., Chief Financial Officer
Holds 12,698 shares of Common Stock |
Loading...
